Methods to improve medication compliance and psychological support for Pazopanib patients

Pazopanib is an oral multi-target tyrosine kinase inhibitor widely used in the treatment of advanced renal cancer and soft tissue sarcoma. Due to the need for long-term medication and long course of treatment, some patients may have adverse effects on medication compliance due to side effects, mood swings or lack of confidence in treatment. Therefore, improving medication compliance is one of the key aspects of successful treatment.

The first step to improve compliance is patient education. Doctors and nurses should explain the mechanism of action, common adverse reactions and management methods of pazopanib to patients in detail to help patients establish reasonable expectations. Written medication instructions can be provided or a health management app can be used to remind patients of daily medication times to help patients form regular medication habits.

At the same time, attention should be paid to the prevention and management of side effects to reduce discontinuation or missed doses due to discomfort. For example, if adverse reactions such as fatigue, diarrhea, or high blood pressure occur, medical staff should promptly make individualized adjustments, including drug intervention and lifestyle guidance, so that patients can feel that treatment is a controllable and promising process, thereby enhancing the motivation to adhere to treatment.

In addition, psychological support is equally important. Long-term anti-cancer treatment can easily cause patients to suffer from anxiety, depression and other emotions. Family members should provide understanding and companionship, and medical staff can provide psychological counseling resources or guide patients to join patient mutual aid groups to share experiences and positive information. Comprehensive intervention can not only improve pazopanib compliance, but also help improve patients' quality of life and overall treatment effect.

References：https://www.votrient.com/